CYCN BullishCYCN Possible Breakout
RSI is not in extreme meaning there is room for price movement in either direction.
If volume supports the momentum, a breakout could occur.
the MLMI suggests strong buying pressure
CYCN trade ideas
+55% in a day $CYCN compared $TSLA $NVDA -5% in drop marketWe can't be the only ones who actually made money overnight from Friday to Monday in this market?
This was the only daytrade held 🎯
NASDAQ:NVDA NASDAQ:TSLA wake up into -5%
Woke up into +25% with NASDAQ:CYCN and continued to +55% from $4 to $6.25+
CycnCyclerion Therapeutics, Inc. (NASDAQ: CYCN)
1. Price Action & Trend Analysis
Current Price: $3.92 (+54.33% on the day)
Post-Market Price: $3.65
52-Week High: Around $9.00
52-Week Low: $1.27
Recent Breakout: The stock has experienced a significant breakout with a sharp price increase.
Resistance Levels: Around $4.00-$4.50 (historical supply zone)
Support Levels: Around $3.00 (previous consolidation area)
2. Indicators Breakdown
MACD Histogram: Showing increasing positive momentum, indicating bullish strength.
Volume Indicators:
Spiking volume, which confirms the breakout.
Purple volume-related indicators suggest strong relative volume compared to historical averages.
Volatility Increase: The price surge suggests heightened market interest, likely due to news or an earnings catalyst.
3. Market Sentiment
Buying Pressure: Strong upside movement, possibly fueled by retail traders and algorithmic buying.
Potential Short Squeeze: If short interest was high, today’s move could be a short-covering rally.
4. Trading Strategy Considerations
Bullish Case:
If momentum sustains, the next target is around $4.50-$5.00.
watch for pullbacks to $3.50-$3.70 for re-entry opportunities.
Bearish Case:
If it fails to hold above $3.50, it may retrace to $3.00.
A high wick on today’s candle could signal profit-taking.
5. Key Takeaways
Watch for Continuation: If volume remains high, the rally could extend.
Monitor Resistance: Break above $4.50 could trigger another leg up.
Stay Cautious: If momentum fades, expect a pullback to $3.00.
MADNESS100
Stay Fokus !
CYCN long idea presenation of trial study phase 2No investment advice!
I do this only for practicing.
Most Info on the chart.
We had a nice volume bounce on July 22 due to announced presentation of clinical trial study.
The presentation should be held July 26- 30.
I would trade the possible pre run up until the presentation.
The outcome of it is 50 / 50
60fib_CYCNPossible entry for this speculative biostock not reaching reverse head and shoulders but if it does catch momentum after the 60fib then it could reverse head and shoulders....indicators bullish
CYCNMultiyear trend break under way. Appears to have had a lot of accumulation over the past few days relative to volume it’s traded in the past. If this multiyear trend break not only breaks, but confirms, I think there might be a bigger picture move in tact for a possible test of the 8-10 area. 4.7 break on the daily chart is key for me, but that doesn’t mean that will be my entry spot. Another one where I would prefer some form of consolidation.
No News Pop For CYCNNo news on April 9th and no filings either. But CYCN jumped to $3.10 after-hours. The initial pop began during the final hours of the afternoon session with a big volume spike that pushed the stock back above $3 for the first time, to the upside, in a few weeks.
A MELAS Phase 2a study is underway. So the market could be waiting for any updated data to shed light on progress. As it stands right now, top-line data is expected in “mid-2021.” There’s also a Phase 2a study on patients who have Alzheimer’s disease with vascular pathology. The company is expected to initiate this in “mid-2021” as well. Does Friday’s aftermarket momentum have anything to do with its current pipeline? We’ll have to see how Monday begins. In the meantime, CYCN could be one of the penny stocks to watch this week.
Quote Source: Best Penny Stocks To Buy Right Now? 3 For This Week’s Watch List
CYCN long term hold This stock is sitting nicely on daily chart, but what it great a hedge fund owns 71 percent of shares, back in december of 2019 hedge fund bought second round of shares and if you look at chart thats when price moved up, this is a long term call but you should be in profit sooner than later
Cycn gap fillLooks like CYCN is fixing to bust out of the 3.70's tomorrow, hopefully with some volume. I might take a second position here.
